See the VIP Duo
in action.
A clinical specialist will walk you through the
device specifications, the science behind the platform, and its potential impact on your practice environment. No pressure, just a peer-level conversation.
Complete Technical Walkthrough
Deep dive into pulse architecture and irradiance regimes.
ROI and Investment Analysis
Transparent discussion of device pricing and practice integration.
No Obligation Policy
We only want our lasers in clinics where they will truly serve patients.
The patient conversation your competition cannot have.
A growing segment of your patient population already owns an OTC red or near-infrared light panel. They are informed, outcome-oriented, and asking a question your competitors cannot answer convincingly: "What can you offer that I can't do at home?"
Patient: "I already have a red light at home."
Your answer: "Home devices are capped by law at low power for safety. AXON operates at clinical-only power levels — up to 100,000 times greater peak output — which is associated with deeper tissue interaction in published research. That's the difference between a flashlight and a searchlight: same principle, very different reach."
Patient: "Is there science behind this?"
Your answer: "This device operates in the VIP Exact Parameter Space, a therapeutic regime governed by threshold interactions that is only accessible at these power levels."
Built for the Regenerative & Integrative Practice.
Regenerative medicine physicians are already fluent in cellular mechanism, hormesis, and dose-response — AXON is the first photobiomodulation platform engineered specifically for that level of clinical sophistication. Chiropractors, physical therapists, and sports medicine practitioners use AXON within the same cleared indications, with protocols adapted to their scope of practice.
PRIMARY AUDIENCE
Outcome-Driven MD in Cash-Pay or Hybrid Practice
ORTHOPEDICS
PAIN MGMT
SPORTS MEDICINE
REGENERATIVE
FDA CLEARED ⃰ • ILY • CLASS II EXEMPT
VIP Duo Laser System.
The photobiomodulation platform Your patients cannot buy at home.
500,000
mW PEAK POWER
810+915
NM DUAL WAVELENGTH
USA
ISO 13485 CERTIFIED
⃰ Mechanism descriptions throughout this page (pulse architecture, threshold effects, cellular pathways) describe proposed, investigational models under active research. They are not themselves FDA-cleared indications. AXON VIP Duo is cleared for the indications listed below.
The business case for a premium
instrument.
Rx-Only
Distinction
The VIP Duo Laser is a
prescription-only, professional-use device. It creates a durable moat against OTC devices and ensures only high-level providers can offer these results.
3+ Billable Lines
Within the cleared indication, the VIP Duo supports targeted
sessions (small spot), broad-area volumetric applications (large spot), and safety-conscious automated treatments.
Premium
Positioning
Practitioners offering
photobiomodulation within the cleared indication are among the elite. This technology justifies premium pricing for cash-pay patient segments.
SESSION FEE
$150–$300
DAILY SESSIONS
5–10
ANNUAL
REVENUE
$165K–
$660K
Why Peak Power Matters
Peak irradiance is the single number that determines whether a laser can reach threshold-level tissue interactions at all. Most consumer and many clinical lasers simply don't generate enough peak power to get there, regardless of treatment time. AXON is engineered specifically to clear that bar.
550 μm fiber tip (bare)
1 cm collimated spot
(minimum)
5.5 cm collimated spot
(maximum)
Leading competitor platform
(1064 nm)
0.00238 cm²
0.785 cm²
23.76 cm²
Varies
210,000,000 mW/cm²
637,000 mW/cm²
21,000 mW/cm²
~15,000,000 mW/cm² max
Maximum photon concentration
Focused biostimulation —
localized structure
Maximum coverage — broad tissue volume
CONFIGURATION
BEAM AREA
PEAK IRRADIANCE
(MW/CM²)
CLINICAL CONTEXT
DEVICE PHYSICAL CHARACTERISTICS
How the VIP Duo Laser System works — Two Effects, One Pulse.
Phase 2 — Standard
Interactions
The trailing portion of each qualifying pulse acts on tissue that has been transiently modified by Phase 1 — those whose photobiological responsiveness is proposed to be expanded beyond its spontaneous baseline state.
•
Augmented photobiomodulation through cytochrome-c oxidase upregulation
•
Elevated hormetic saturation ceiling via high-density energy delivery
•
Durable biological consequences and prolonged cell signaling cycles
Phase 1 — Transient
Interaction
Think of it like the difference between a gentle rain and a single, intense drop hitting a window. Both are water — but only the high-velocity drop momentarily flexes the glass. AXON's pulse architecture is engineered to briefly cross a power threshold that conventional PBM and Class IV lasers don't reach. Preclinical research suggests this brief, high-intensity phase may engage tissue-level mechanisms beyond standard light therapy — a hypothesis under active investigation in our ongoing research program.
•
Mechanical photomechanical effects via structural bond relaxation
•
Above-threshold photochemical interactions
•
Hyper-localized photothermal events at sub-millimeter scales
Mechanism descriptions are based on proposed, investigational models and have not been reviewed by FDA in connection with this device's cleared indication.
Two Chromophores. One Pulse.
Picture two keys turning two different locks at once.
-
The 810 nm wavelength is tuned to cytochrome c oxidase — the mitochondrial enzyme most responsible for cellular energy production.
-
The 915 nm wavelength is tuned to oxyhemoglobin, addressing local tissue oxygenation.
-
AXON delivers both through a single fiber, at the same moment, to the same tissue volume.
Evidence regarding cellular mechanisms reflects preclinical and emerging literature; these pathways are not themselves FDA-cleared indications.
810
810 nm
TARGET: cytochrome c oxidase
The 810 nm wavelength sits at the peak primary absorption peak of CCO, the terminal enzyme of the mitochondrial electron transport chain. By increasing the mitochondrial proton gradient, it facilitates oxygen consumption and cellular energy production.
Simultaneous
Delivery
Co-incident architecture ensures both wavelengths target the same tissue volume at the exact same millisecond.
915
915 nm
TARGET: OXYHEMOGLOBIN
The 915 nm wavelength falls within the absorption band of oxyhemoglobin, the oxygen-carrying form of hemoglobin
present in tissue microvasculature. This targets the mitochondrial microenvironment to modulate local tissue oxygenation.
VIP Duo Technical
System Specs v2.4
Pulse Architecture
Wavelength Design
Irradiance Regime
Clinical Applications
Practice Economics